Liminal BioSciences Statistics Share Statistics Liminal BioSciences has 3.25M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 3.25M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 1.26M Failed to Deliver (FTD) Shares 1,714 FTD / Avg. Volume 7.22%
Short Selling Information The latest short interest is 675, so 0.02% of the outstanding
shares have been sold short.
Short Interest 675 Short % of Shares Out 0.02% Short % of Float 0.05% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.01 and the forward
PE ratio is null.
Liminal BioSciences's PEG ratio is
0.
PE Ratio -0.01 Forward PE n/a PS Ratio 0.93 Forward PS n/a PB Ratio 0.01 P/FCF Ratio -0.01 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Liminal BioSciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.09,
with a Debt / Equity ratio of 0.04.
Current Ratio 4.09 Quick Ratio 4.09 Debt / Equity 0.04 Debt / EBITDA -0.05 Debt / FCF -0.05 Interest Coverage -30.59
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.6K Profits Per Employee $-115.2K Employee Count 251 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax -525K Effective Tax Rate 1.78%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.03, so Liminal BioSciences's
price volatility has been higher than the market average.
Beta 1.03 52-Week Price Change n/a 50-Day Moving Average 8.41 200-Day Moving Average 6.25 Relative Strength Index (RSI) 77.1 Average Volume (20 Days) 23,725
Income Statement In the last 12 months, Liminal BioSciences had revenue of 401K
and earned -28.92M
in profits. Earnings per share was -341.8.
Revenue 401K Gross Profit 401K Operating Income -32.98M Net Income -28.92M EBITDA -31.86M EBIT -24.3M Earnings Per Share (EPS) -341.8
Full Income Statement Balance Sheet The company has 37.14M in cash and 1.49M in
debt, giving a net cash position of 35.66M.
Cash & Cash Equivalents 37.14M Total Debt 1.49M Net Cash 35.66M Retained Earnings -1.08B Total Assets 31.8M Working Capital 16.4M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -31.82M
and capital expenditures -19K, giving a free cash flow of -31.84M.
Operating Cash Flow -31.82M Capital Expenditures -19K Free Cash Flow -31.84M FCF Per Share -376.35
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -8223.19% and -7210.97%.
Gross Margin 100% Operating Margin -8223.19% Pretax Margin -7341.9% Profit Margin -7210.97% EBITDA Margin -7943.89% EBIT Margin -8223.19% FCF Margin -7939.9%
Dividends & Yields LMNL does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for LMNL.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 1, 2023. It was a
backward
split with a ratio of 1:10.
Last Split Date Feb 1, 2023 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -49.69 Piotroski F-Score 5
